BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28875490)

  • 1. Immune Cell Metabolism in Tumor Microenvironment.
    Li Y; Wan YY; Zhu B
    Adv Exp Med Biol; 2017; 1011():163-196. PubMed ID: 28875490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate and Adaptive Immune Cell Metabolism in Tumor Microenvironment.
    Wu D
    Adv Exp Med Biol; 2017; 1011():211-223. PubMed ID: 28875492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Metabolism and Tumor Antigen Presentation.
    Qin H; Chen Y
    Adv Exp Med Biol; 2021; 1316():169-189. PubMed ID: 33740250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunometabolic Interplay in the Tumor Microenvironment.
    Kaymak I; Williams KS; Cantor JR; Jones RG
    Cancer Cell; 2021 Jan; 39(1):28-37. PubMed ID: 33125860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy.
    Lian X; Yang K; Li R; Li M; Zuo J; Zheng B; Wang W; Wang P; Zhou S
    Mol Cancer; 2022 Jan; 21(1):27. PubMed ID: 35062950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward Normalization of the Tumor Microenvironment for Cancer Therapy.
    Zheng J; Gao P
    Integr Cancer Ther; 2019; 18():1534735419862352. PubMed ID: 31282197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation in the tumor microenvironment.
    Zhang MW; Fujiwara K; Che X; Zheng S; Zheng L
    J Zhejiang Univ Sci B; 2017 May; 18(5):365-372. PubMed ID: 28471108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid metabolism in tumor: New shine in the fog?
    Qiu H; Shao N; Liu J; Zhao J; Chen C; Li Q; He Z; Zhao X; Xu L
    Clin Nutr; 2023 Aug; 42(8):1521-1530. PubMed ID: 37321900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
    Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
    Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the microenvironment in solid tumors.
    Belli C; Trapani D; Viale G; D'Amico P; Duso BA; Della Vigna P; Orsi F; Curigliano G
    Cancer Treat Rev; 2018 Apr; 65():22-32. PubMed ID: 29502037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy.
    Zhang M; Wei T; Zhang X; Guo D
    Front Immunol; 2022; 13():937406. PubMed ID: 36131916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy.
    Meng MB; Wang HH; Cui YL; Wu ZQ; Shi YY; Zaorsky NG; Deng L; Yuan ZY; Lu Y; Wang P
    Oncotarget; 2016 Aug; 7(35):57391-57413. PubMed ID: 27429198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Microenvironment of Lung Cancer and Therapeutic Implications.
    Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
    Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential role of miRNAs in orchestrating the biology of the tumor microenvironment.
    Frediani JN; Fabbri M
    Mol Cancer; 2016 May; 15(1):42. PubMed ID: 27231010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism within the tumor microenvironment and its implication on cancer progression: An ongoing therapeutic target.
    Ocaña MC; Martínez-Poveda B; Quesada AR; Medina MÁ
    Med Res Rev; 2019 Jan; 39(1):70-113. PubMed ID: 29785785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in Cancer Metabolism: New Concepts in an Old Field.
    Gentric G; Mieulet V; Mechta-Grigoriou F
    Antioxid Redox Signal; 2017 Mar; 26(9):462-485. PubMed ID: 27228792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Reprogramming of Immune Cells in Cancer Progression.
    Biswas SK
    Immunity; 2015 Sep; 43(3):435-49. PubMed ID: 26377897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunometabolism in the Bladder Cancer Microenvironment.
    Fattahi MJ; Haghshenas MR; Ghaderi A
    Endocr Metab Immune Disord Drug Targets; 2022; 22(12):1201-1216. PubMed ID: 34983357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer.
    Anari F; Ramamurthy C; Zibelman M
    Future Oncol; 2018 Jun; 14(14):1409-1421. PubMed ID: 29848096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.
    Yang S; Gao H
    Pharmacol Res; 2017 Dec; 126():97-108. PubMed ID: 28501517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.